ARCA Pharmaceutical

The NYSE Arca Pharmaceutical Index (DRG) is a market capitalization weighted index designed to represent a cross section of widely held, highly capitalized companies involved in various phases of the development, production, and marketing of pharmaceuticals. The index value was split 2-for-1 on March 23, 1999.

The current value of ARCA Pharmaceutical is 934.33 — it has decreased by -0.65% in the past 24 hours. Watch ARCA Pharmaceutical performance more closely on the advanced chart.

ARCA Pharmaceutical has decreased by -0.65% in the last 24 hours, has decreased by 0.00% in past week, has increased by 0.70% in the past month, and has decreased by -11.12% in the past year. See more data on the ARCA Pharmaceutical chart.

As of 05 Jul 2025, the largest companies by index weight include Prestige Brand Holdings Inc, Bristol-Myers Squibb Company, Alkermes Plc, Eli Lilly and Company, Zoetis Inc, Jazz Pharmaceuticals PLC. See the full list of {{name}} components.

The ARCA Pharmaceutical consists of 24 components, including Prestige Brand Holdings Inc, Bristol-Myers Squibb Company, Alkermes Plc and others. See the full list of ARCA Pharmaceutical components.

As of 05 Jul 2025, the ARCA Pharmaceutical consists of a total 24 stocks. See the full list of ARCA Pharmaceutical components.

The ARCA Pharmaceutical sectors include Healthcare and more.

ARCA Pharmaceutical is benchmare that tracks the performance of the components comprised in the index, so you can't invest in the index directly. However, you can buy ARCA Pharmaceutical futures or invest through Index Funds or ETFs that replicate the performance of the index.